1. 199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study. (23rd October 2018) Authors: Prat, A; Adamo, B; Perez Fidalgo, J A; Blanch, S; Martinez, N; Gomez Pardo, P; López González, A; Murillo Juso, L; Amillano, K; Vidal, M; Pascual, T; Pare, L; Canes, J; Galvan, P; Gonzalez Farre, B; Ortega Cebrian, V; Gonzalez, X; Bellet Ezquerra, M; Villagrasa, P; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗